Articles

Allison Carey, MD, PhD, pictured in her lab at the University of Utah, developed a molecular barcoding approach to identify genetic variants that make some strains of Mycobacterium avium more resistant to antibiotics.

ARUP Consult^®, a free source of laboratory testing information for clinicians, released several new and updated resources in January.

Erik Forsman draws on his seven years of experience as a healthcare data consultant to share the foundations of a holistic, in-house data analytic system in a new Journal of Applied Laboratory Medicine (JALM) article.

Nathan Boggs, MD, PhD, an assistant professor of medicine at the Uniformed Services University who is engaged in systemic mastocytosis (SM) translational research, helped Mark Withers, MD, obtain a definitive diagnosis of SM after 20-plus years. Tracy George, MD, ARUP Laboratories president and chief scientific officer, has led the effort to develop highly sensitive tests at ARUP that aid in the diagnosis of SM and has played a key role in clinical trials for emerging treatments.

Cases of respiratory syncytial virus (RSV), influenza, and COVID-19 in children, older adults, and other vulnerable populations are on the rise and warrant laboratory testing to inform treatment.

Tony Smith, BS(HCM), MLT(ASCP), senior healthcare consultant at ARUP Laboratories, is the author of a newly published article in Clinical Laboratory News that offers guidelines for creating strong governance structures to ensure sustainability of laboratory stewardship programs.

ARUP Consult^®, a free source of laboratory testing information for clinicians, released several new and updated resources in December.

Jennifer (Jenna) Rychert, PhD, ARUP medical director of Operational Informatics and Microbial Immunology, and Jonathan Genzen, MD, PhD, ARUP chief medical officer, coauthored the report of the new study, “Laboratory-Developed Test Orders in an Academic Health System.”

ARUP Consult^®, a free source of laboratory testing information for clinicians, released several new and updated resources in November.

The condition of venous thromboembolism, illustrated here, can be treated using direct oral anticoagulants (DOACs) such as direct factor Xa inhibitors. ARUP’s new chromogenic assays can be used to help assess treatment efficacy.

ARUP Chief Medical Officer Jonathan Genzen, MD, PhD (left), and Lauren Pearson, DO, MPH, chief medical officer of ARUP at University of Utah Health, are coauthors of a newly published JAMA Research Letter that summarizes results of a survey of clinical labs to evaluate adoption of a new equation to assess kidney function based on creatinine in patient serum. The new equation eliminates adjustment factors for race.